ASTM perking, remember last run?, maybe in stride with old rat GENE, GNLB a poor mans play, perhaps. CTB up today, selling out. Sold ALLP yesterday, and of course it popped into 3.70 early... Just received the BIPL annual report, I think it will have a good run over the next 52 weeks, as new testing products are introduced. They are going into some stuff aimed toward food safety & pollution. Amazingly, they are also working with the Dept. of Defense on some stuff, the Dept. of Agriculture, Centers for Disease Control, and the National Cancer Institute on Gene Expression. So, I say it again, BIPL is by far the cheapest way into the genomic research field. However, I want to buy/add at a lower level.
Hey, INVN bidding 3.50, will wonders never cease! Added some today @3.35 Also was adding when it was 2.60 2 weeks back. I am looking for a major move, but it needs to take out 3.80 soon, or the rally could stall. |